Low-dose cyclophosphamide and low-dose interleukin-2 for malignant melanoma.

We have studied the effects of low-dose recombinant interleukin-2 preceded by low-dose cyclophosphamide on malignant melanoma. Thirty eight outpatients aged from 25 to 75 years were treated with interleukin-2, 3.6 million Cetus units/m2 i.v. daily for five days on two successive weeks beginning thre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mitchell, M. S., Kempf, R. A., Harel, W., Shau, H., Boswell, W. D., Lind, S., Dean, G., Moore, J., Bradley, E. C.
Formato: Artigo
Idioma:Inglês
Publicado em: 1989
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1807785/
https://ncbi.nlm.nih.gov/pubmed/2532554
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados